Morten Salomo

2.1k total citations
29 papers, 344 citations indexed

About

Morten Salomo is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Morten Salomo has authored 29 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hematology, 15 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Morten Salomo's work include Multiple Myeloma Research and Treatments (24 papers), Protein Degradation and Inhibitors (6 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers). Morten Salomo is often cited by papers focused on Multiple Myeloma Research and Treatments (24 papers), Protein Degradation and Inhibitors (6 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers). Morten Salomo collaborates with scholars based in Denmark, United States and Germany. Morten Salomo's co-authors include Peter Gimsing, Annette Juul Vangsted, Tobias Wirenfeldt Klausen, Rasmus Sørrig, Gitte Lee Mortensen, Ulf Christian Frølund, Niels Abildgaard, Carsten Helleberg, Robert S. Pedersen and Per Trøllund Pedersen and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Morten Salomo

26 papers receiving 339 citations

Peers

Morten Salomo
Danai Dima United States
E. Stadtmauer United States
Christy Samaras United States
Michelle E. Maglio United States
MQ Lacy United States
MA Gertz United States
Ulrike Buttkereit Germany
Miquel Granell Spain
Dieter Brandhorst Germany
Liya Ma China
Danai Dima United States
Morten Salomo
Citations per year, relative to Morten Salomo Morten Salomo (= 1×) peers Danai Dima

Countries citing papers authored by Morten Salomo

Since Specialization
Citations

This map shows the geographic impact of Morten Salomo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morten Salomo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morten Salomo more than expected).

Fields of papers citing papers by Morten Salomo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morten Salomo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morten Salomo. The network helps show where Morten Salomo may publish in the future.

Co-authorship network of co-authors of Morten Salomo

This figure shows the co-authorship network connecting the top 25 collaborators of Morten Salomo. A scholar is included among the top collaborators of Morten Salomo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morten Salomo. Morten Salomo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Talbot, Alexis, Cyrille Hulin, Aurore Perrot, et al.. (2025). Retreatment With Anti-CD38-Based Combinations in Multiple Myeloma in Real-Life: Results From the Emmy Cohort Study. Clinical Lymphoma Myeloma & Leukemia. 25(12). 863–872. 1 indexed citations
3.
Rückert, Michael, Mamta Garg, Ceri Bygrave, et al.. (2024). Evolution of Treatment Patterns and Survival Outcomes in European Patients with Multiple Myeloma from 2012-2023 through the Honeur Federated Data Network. Blood. 144(Supplement 1). 2388–2388.
4.
Butt, Jawad H., Finn Gustafsson, Morten Schou, et al.. (2021). Two Decades of Cardiac Amyloidosis. JACC CardioOncology. 3(4). 522–533. 30 indexed citations
5.
Achiam, Michael Patrick, et al.. (2021). Extramedullary relapse in a patient with multiple myeloma: a rare cause of gastrointestinal perforation and massive bleeding. BMJ Case Reports. 14(11). e243663–e243663.
6.
7.
Dimopoulos, Meletios Α., Katja Weisel, Philippe Moreau, et al.. (2020). Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM): outcomes by prior treatment at first relapse. Leukemia. 35(6). 1722–1731. 41 indexed citations
8.
Dimopoulos, Meletios Α., Katja Weisel, Philippe Moreau, et al.. (2020). POMALIDOMIDE, BORTEZOMIB, DEXAMETHASONE AFTER 1 PRIOR LINE OF THERAPY IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: SUBANALYSIS OF OPTIMMISM BY AGE, PRIOR TRANSPLANT, AND HIGH-RISK CYTOGENETICS. Hematology Transfusion and Cell Therapy. 42. 272–273. 1 indexed citations
9.
Rasmussen, P, Jens Folke Kiilgaard, & Morten Salomo. (2019). Association of Choroidal Effusion and Infusion of Daratumumab. JAMA Ophthalmology. 137(7). 853–853. 6 indexed citations
10.
Roussel, Murielle, Bertrand Arnulf, Anne‐Marie Stoppa, et al.. (2019). A Prospective Phase II of Daratumumab in Previously Treated Systemic Light-Chain (AL) Amyloidosis: Updated Results. Clinical Lymphoma Myeloma & Leukemia. 19(10). e40–e41. 4 indexed citations
11.
12.
Sørrig, Rasmus, Tobias Wirenfeldt Klausen, Morten Salomo, Annette Juul Vangsted, & Peter Gimsing. (2018). Risk factors for blood stream infections in multiple myeloma: A population‐based study of 1154 patients in Denmark. European Journal Of Haematology. 101(1). 21–27. 22 indexed citations
13.
Sørrig, Rasmus, Tobias Wirenfeldt Klausen, Morten Salomo, et al.. (2017). Immunoparesis in newly diagnosed Multiple Myeloma patients: Effects on overall survival and progression free survival in the Danish population. PLoS ONE. 12(12). e0188988–e0188988. 37 indexed citations
14.
15.
Hansson, Markus, Peter Gimsing, Ashraf Badros, et al.. (2015). A Phase I Dose-Escalation Study of Antibody BI-505 in Relapsed/Refractory Multiple Myeloma. Clinical Cancer Research. 21(12). 2730–2736. 42 indexed citations
16.
Sørrig, Rasmus, Tobias Wirenfeldt Klausen, Morten Salomo, et al.. (2015). Smoldering multiple myeloma risk factors for progression: a Danish population‐based cohort study. European Journal Of Haematology. 97(3). 303–309. 45 indexed citations
17.
Salomo, Morten, et al.. (2013). How to exhaust your bone marrow. BMJ Case Reports. 2013. bcr2013009210–bcr2013009210. 2 indexed citations
18.
Hansen, Morten Bagge, Peter R. Galle, Morten Salomo, et al.. (2007). Transfusion‐related inhibition of cytokines (TRICK). Experimental transfer of neutralizing autoantibodies to interleukin‐6 by plasma transfusions. Vox Sanguinis. 92(3). 213–223. 6 indexed citations
19.
Salomo, Morten, et al.. (2003). How myeloma cells escape bisphosphonate‐mediated killing: development of specific resistance with preserved sensitivity to conventional chemotherapeutics. British Journal of Haematology. 122(2). 202–210. 19 indexed citations
20.
Salomo, Morten, Peter Gimsing, & Lars Bøgeskov Nielsen. (2002). Simple Method for Quantification of Bence Jones Proteins. Clinical Chemistry. 48(12). 2202–2207. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Danai Dima Breakdown of academic impact, for papers by E. Stadtmauer Breakdown of academic impact, for papers by Christy Samaras Breakdown of academic impact, for papers by Michelle E. Maglio Breakdown of academic impact, for papers by MQ Lacy Breakdown of academic impact, for papers by MA Gertz Breakdown of academic impact, for papers by Ulrike Buttkereit Breakdown of academic impact, for papers by Miquel Granell Breakdown of academic impact, for papers by Dieter Brandhorst Breakdown of academic impact, for papers by Liya Ma
Rankless by CCL
2026